Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Return on Invested Capital (2017 - 2025)

Historic Return on Invested Capital for Vanda Pharmaceuticals (VNDA) over the last 10 years, with Q4 2025 value amounting to 0.6%.

  • Vanda Pharmaceuticals' Return on Invested Capital fell 5400.0% to 0.6% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.6%, marking a year-over-year decrease of 5400.0%. This contributed to the annual value of 0.55% for FY2025, which is 4900.0% down from last year.
  • As of Q4 2025, Vanda Pharmaceuticals' Return on Invested Capital stood at 0.6%, which was down 5400.0% from 0.2% recorded in Q3 2025.
  • Over the past 5 years, Vanda Pharmaceuticals' Return on Invested Capital peaked at 0.07% during Q3 2021, and registered a low of 0.6% during Q4 2025.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.0% (2022), whereas its average is 0.05%.
  • As far as peak fluctuations go, Vanda Pharmaceuticals' Return on Invested Capital soared by 300bps in 2021, and later tumbled by -5400bps in 2025.
  • Over the past 5 years, Vanda Pharmaceuticals' Return on Invested Capital (Quarter) stood at 0.07% in 2021, then crashed by -90bps to 0.01% in 2022, then crashed by -250bps to 0.01% in 2023, then tumbled by -509bps to 0.06% in 2024, then crashed by -871bps to 0.6% in 2025.
  • Its last three reported values are 0.6% in Q4 2025, 0.2% for Q3 2025, and 0.16% during Q2 2025.